Ann Honebrink MD, FACOG
Associate Professor, Clinical Obstetrics and Gynecology, University of Pennsylvania
- Obstetrician/gynecologist specializing in the care of people during and after menopause
- Medical director of Penn Health for Women at Radnor, a multidisciplinary program providing care for women of all ages
- Recipient of a 2020 Outstanding District Service Award from American College of Obstetricians and Gynecologists
Anne Honebrink, MD, FACOG, is a board certified obstetrician/gynecologist and an associate professor of clinical obstetrics and gynecology at the University of Pennsylvania.
She is the medical director of Penn Health for Women at Radnor, a multidisciplinary program providing care for women of all ages. Her clinical practice focuses on gynecology and she has a particular interest in the care of women during and after menopause. Her practice includes many women with a history of breast cancer.
Dr. Honebrink is the director of the obstetrics and gynecology medical student clerkship at the University of Pennsylvania Perelman School of Medicine and is active in the leadership of the American College of Obstetricians and Gynecologists.
Some women report worse side effects after ovarian suppression
In this sub-study of the SOFT clinical trial, premenopausal women with hormone receptor-positive breast cancer who took tamoxifen and ovarian suppression had more menopausal symptoms over 2 years than women who took tamoxifen alone.